title: Reconstituted high-density lipoprotein modulates activation of human leukocytes.
abstract: An anti-inflammatory effect of reconstituted High Density Lipoprotein (rHDL) has been demonstrated in atherosclerosis and in sepsis models. An increase of adhesion molecules as well as tissue factor expression on endothelial cells in response to inflammatory or danger signals are attenuated by the treatment with rHDL. Here we show the inhibitory effect of rHDL on the activation of human leukocytes in a whole blood assay as well as on monocyte-derived human dendritic cells (DC). Multiplex analysis of human whole blood showed that phytohaemagglutinin (PHA)-induced secretion of the cytokines IL-1β, IL-1RA, IL-2R, IL-6, IL-7, IL-12(p40), IL-15 and IFN-α was inhibited. Furthermore, an inhibitory effect on the production of the chemokines CCL-2, CCL-4, CCL-5, CXCL-9 and CXCL-10 was observed. Activation of granulocytes and CD14+ monocytes by PHA is inhibited dose-dependently by rHDL shown as decreased up-regulation of ICAM-1 surface expression. In addition, we found a strong inhibitory effect of rHDL on toll-like receptor 2 (TLR2)- and TLR4-mediated maturation of DC. Treatment of DC with rHDL prevented the up-regulation of cell surface molecules CD80, CD83 and CD86 and it inhibited the TLR-driven activation of inflammatory transcription factor NF-κB. These findings suggest that rHDL prevents activation of crucial cellular players of cellular immunity and could therefore be a useful reagent to impede inflammation as well as the link between innate and adaptive immunity.
authors: Laboratory of Cardiovascular Research, Department of Clinical Research, University of Bern, Bern, Switzerland.
authors: Rolf
authors: R
authors: Spirig
authors: Alexander
authors: A
authors: Schaub
authors: Alain
authors: A
authors: Kropf
authors: Sylvia
authors: S
authors: Miescher
authors: Martin O
authors: MO
authors: Spycher
authors: Robert
authors: R
authors: Rieben
mesh_terms: D051940:B7-2 Antigen / Q000378:metabolism; D018925:Chemokines / Q000378:metabolism; D003713:Dendritic Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D006098:Granulocytes / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D007700:Kinetics; D007962:Leukocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D018950:Lipopolysaccharide Receptors / Q000378:metabolism; D008075:Lipoproteins, HDL / Q000494:pharmacology*; D009000:Monocytes / Q000166:cytology; D016328:NF-kappa B / Q000378:metabolism; D051195:Toll-Like Receptor 2 / Q000378:metabolism; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D051940:B7-2 Antigen; D018925:Chemokines; D018950:Lipopolysaccharide Receptors; D008075:Lipoproteins, HDL; D016328:NF-kappa B; D051195:Toll-Like Receptor 2; D018799:Intercellular Adhesion Molecule-1
references: Nat Rev Immunol. 2006 Mar;6(3):173-82
references: 16498448
references: Atherosclerosis. 2009 Mar;203(1):137-44
references: 18606412
references: Biochim Biophys Acta. 2012 Mar;1821(3):513-21
references: 21864714
references: Blood. 2001 Apr 15;97(8):2381-9
references: 11290601
references: JAMA. 2007 Apr 18;297(15):1675-82
references: 17387133
references: Annu Rev Immunol. 2010;28:321-42
references: 20307211
references: J Cardiovasc Pharmacol Ther. 2012 Sep;17(3):315-23
references: 22067613
references: Atherosclerosis. 2012 Jan;220(1):11-21
references: 21783193
references: Infect Immun. 2003 Aug;71(8):4382-8
references: 12874316
references: Nat Rev Immunol. 2003 Feb;3(2):133-46
references: 12563297
references: Eur J Immunol. 2000 Jul;30(7):1807-12
references: 10940869
references: Nat Rev Immunol. 2010 Mar;10(3):170-81
references: 20154735
references: J Immunol. 2008 Jul 15;181(2):878-90
references: 18606639
references: Curr Opin Immunol. 2010 Jun;22(3):333-40
references: 20363604
references: J Clin Endocrinol Metab. 1999 Aug;84(8):2834-9
references: 10443688
references: Cell Metab. 2010 Aug 4;12(2):142-53
references: 20674859
references: J Clin Invest. 2005 Oct;115(10):2894-903
references: 16167081
references: Eur Heart J. 2010 Jun;31(12):1457-69
references: 20447947
references: Nature. 1998 Mar 19;392(6673):245-52
references: 9521319
references: J Lipid Res. 1999 Feb;40(2):245-52
references: 9925653
references: Immunity. 2009 Aug 21;31(2):245-58
references: 19646905
references: Ann Rheum Dis. 2004 Jun;63(6):747-8
references: 15140788
references: Circ Res. 2012 Nov 9;111(11):1398-409
references: 22955730
references: Circulation. 2005 Mar 29;111(12):1543-50
references: 15781735
references: PLoS One. 2010 Jun 07;5(6):e0010983
references: 20539755
references: J Leukoc Biol. 1999 Dec;66(6):876-88
references: 10614768
references: Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2071-7
references: 18617650
references: Immunity. 2010 Oct 29;33(4):464-78
references: 21029958
references: Circulation. 2002 Mar 26;105(12):1399-402
references: 11914243
references: Immunobiology. 2012 Jan;217(1):91-9
references: 21856032
references: Cell Immunol. 1986 Sep;101(2):312-9
references: 3757046
references: J Exp Med. 2002 Jan 7;195(1):99-111
references: 11781369
references: J Immunol. 2000 Dec 1;165(11):6037-46
references: 11086035
references: Blood. 2003 Jan 15;101(2):758-65
references: 12393386
references: Eur J Immunol. 1991 Nov;21(11):2887-90
references: 1936126
references: J Immunol. 2004 Nov 15;173(10):5901-7
references: 15528321
references: J Biol Chem. 1999 Jun 18;274(25):17406-9
references: 10364168
references: J Clin Invest. 2007 Oct;117(10):2847-59
references: 17853945
references: J Exp Med. 1996 Nov 1;184(5):1601-8
references: 8920850
references: Biochem J. 1999 Oct 1;343 Pt 1:71-5
references: 10493913
references: Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1333-41
references: 21474825
references: Curr Opin Immunol. 2008 Feb;20(1):52-60
references: 18160272
references: Am J Pathol. 2006 Dec;169(6):2127-36
references: 17148675
references: Circulation. 2001 Nov 20;104(21):2588-94
references: 11714655
references: Nat Rev Immunol. 2011 Jul 25;11(8):519-31
references: 21785456
references: Biochem Biophys Res Commun. 2005 Dec 16;338(2):1126-36
references: 16259956
references: Annu Rev Pathol. 2006;1:297-329
references: 18039117
references: J Exp Med. 1994 Apr 1;179(4):1109-18
references: 8145033
references: Nat Rev Immunol. 2010 Dec;10(12):826-37
references: 21088683
references: Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10359-63
references: 7479784
references: J Mol Cell Cardiol. 2010 Apr;48(4):789-98
references: 19665464
references: Eur J Immunol. 1988 Jan;18(1):35-9
references: 3257922
references: J Biol Chem. 2007 Jun 22;282(25):18265-18275
references: 17400552
references: Nat Rev Immunol. 2004 Jul;4(7):499-511
references: 15229469
references: Circ Res. 2003 Feb 21;92(3):330-7
references: 12595346
references: Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1773-8
references: 20702809
references: Circ Res. 2005 Apr 29;96(8):881-9
references: 15774854
references: Circ Res. 2008 Nov 7;103(10):1084-91
references: 18832751
references: J Exp Med. 1990 Apr 1;171(4):1363-8
references: 2139104
references: Circulation. 2004 May 4;109(17):2116-22
references: 15078800
references: J Exp Med. 2005 Oct 3;202(7):913-8
references: 16186183
references: Nat Rev Immunol. 2007 Aug;7(8):610-21
references: 17627284
references: Circ Res. 2004 Feb 6;94(2):253-61
references: 14656931
references: Circ Res. 2009 Feb 27;104(4):455-65
references: 19122179
references: Circ Res. 2004 Apr 16;94(7):918-25
references: 14988229
references: Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1542-8
references: 18483405
references: Kidney Int. 2002 Oct;62(4):1160-70
references: 12234286
references: Br Heart J. 1990 Feb;63(2):82-7
references: 2317413
references: Science. 2010 Jun 25;328(5986):1689-93
references: 20488992
references: Vox Sang. 1996;71(3):155-64
references: 8912458
references: Transplantation. 2011 Jul 27;92(2):131-8
references: 21577179
references: J Cell Physiol. 1996 Sep;168(3):625-37
references: 8816917